aurobindo pharma (ICICIsec) Results inline; Growth remains intact

Strong ANDA pipeline; Plans of restructuring
Date Rating Target Price Recommendation Price Broker house
11 May 2011 strong buy 257 193 ICICI securities Report

No comments:

Post a Comment